Intermittent Catheters Market by Product, Indication, Category, and End User - Global Opportunity Analysis and Industry Forecast, 2016-2023

  • ID: 4580500
  • Report
  • Region: Global
  • 270 pages
  • Allied Analytics LLP
1 of 4
The global intermittent catheters market was valued at $1,655.5 million in 2016, and is expected to reach $2,950.7 million by 2023 with a CAGR of 8.7% during the forecast period. Intermittent catheter is a disposable medical device, which is used to drain the urinary bladder when an individual is unable to do it naturally. Intermittent catheter consists of a drainage bag that assists to capture the urine. These catheters are composed of silicone, PVC, or vinyl or red rubber latex.

The growth of the intermittent catheters market is driven by increase in incidence of urinary incontinence coupled with rise in geriatric population and surge in need for minimally invasive surgeries. In addition, increase in preference of hydrophilic intermittent catheters is expected to supplement the market growth. However, the availability of substitutes of intermittent catheters and lack of awareness towards novel intermittent catheters impede the market growth. On the contrary, innovations in catheters and novel product launches are anticipated to provide lucrative opportunities for the market expansion.

The global intermittent catheters market is segmented based on product, indication, category, end user, and region. On the basis of product, the market is bifurcated into uncoated intermittent catheters and coated intermittent catheters. Coated intermittent catheters are further classified into antimicrobial, hydrophilic, and others. Based on indication, the market is categorized into urinary incontinence, spinal cord injuries, general surgery, and others. By category, it is divided into female length catheter, male length catheters, and kid length catheter. Depending on end user, it is fragmented into hospitals, ambulatory surgical centers, and medical research centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS

The study provides an in-depth analysis of the global intermittent catheters market with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps to understand the products and technologies used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market

KEY MARKET SEGMENTS

By Product

Uncoated Intermittent Catheters
Coated Intermittent Catheters
Hydrophilic
Antimicrobial
Others

By Indication

Urinary Incontinence
Spinal Cord Injuries
General Surgery
Others

By Category

Female Length Catheter
Male Length Catheters
Kid Length Catheter

By End User

Hospitals
Ambulatory Surgical Centers
Medical Research Centers

By Region

North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Rest of Europe
Asia-Pacific
India
China
Japan
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Turkey
South Africa
Saudi Arabia
Rest of LAMEA

KEY PLAYERS PROFILED

Adapta Medical
B. Braun Melsungen AG
Becton Dickinson Company
Coloplast A/S
ConvaTec Healthcare B S.à.r.l
Cure Medical
Hollister Inc.
Medical Technologies of Georgia Inc.
Pennine Healthcare
Teleflex Incorporated
READ MORE
Note: Product cover images may vary from those shown
2 of 4
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2015-2018*
3.2.4. Top winning strategies, by development, 2015-2018* (%)
3.2.5. Top winning strategies, by company, 2015-2018*
3.3. Porters five forces analysis
3.4. Market share analysis, 2016
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in incidence of urinary incontinence
3.5.1.2. Rise in geriatric population
3.5.1.3. Favorable reimbursement policies
3.5.1.4. Rise in preference towards hydrophilic catheters
3.5.2. Restraints
3.5.2.1. Price competition at domestic level
3.5.2.2. Availability of alternatives to intermittent catheters
3.5.2.3. Lack of awareness towards various urological disorders
3.5.3. Opportunities
3.5.3.1. Emerging economies to offer lucrative opportunities
3.5.3.2. Innovations in catheters and novel product launches

CHAPTER 4: INTERMITTENT CATHETERS MARKET, BY PRODUCT
4.1. Overview
4.2. Market size and forecast
4.3. Uncoated intermittent catheters
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Coated intermittent catheters
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.4.4. Antimicrobial intermittent catheters
4.4.4.1. Market size and forecast
4.4.5. Hydrophilic intermittent catheters
4.4.5.1. Market size and forecast
4.4.6. Other intermittent catheters
4.4.6.1. Market size and forecast

CHAPTER 5: INTERMITTENT CATHETERS MARKET, BY INDICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Urinary incontinence
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Spinal cord injuries
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. General surgery
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country

CHAPTER 6: INTERMITTENT CATHETERS MARKET, BY CATEGORY
6.1. Overview
6.1.1. Market size and forecast
6.2. Female length catheters
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Male length catheters
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Kid length catheters
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country

CHAPTER 7: INTERMITTENT CATHETERS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Hospitals
7.2.1. Market size and forecast, by region
7.2.2. Market analysis, by country
7.3. Ambulatory surgical centers
7.3.1. Market size and forecast, by region
7.3.2. Market analysis, by country
7.4. Medical research centers
7.4.1. Market size and forecast, by region
7.4.2. Market analysis, by country

CHAPTER 8: INTERMITTENT CATHETERS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key trends and opportunities
8.2.2. North America market size and forecast, by country
8.2.2.1. U.S. market size and forecast, by product
8.2.2.2. U.S. market size and forecast, by indication
8.2.2.3. U.S. market size and forecast, by category
8.2.2.4. U.S. market size and forecast, by end user
8.2.2.5. Canada market size and forecast, by product
8.2.2.6. Canada market size and forecast, by indication
8.2.2.7. Canada market size and forecast, by category
8.2.2.8. Canada market size and forecast, by end user
8.2.2.9. Mexico market size and forecast, by product
8.2.2.10. Mexico market size and forecast, by indication
8.2.2.11. Mexico market size and forecast, by category
8.2.2.12. Mexico market size and forecast, by end user
8.2.3. North America market size and forecast, by product
8.2.4. North America market size and forecast, by indication
8.2.5. North America market size and forecast, by category
8.2.6. North America market size and forecast, by end user
8.3. Europe
8.3.1. Key trends and opportunities
8.3.2. Europe market size and forecast, by country
8.3.2.1. France market size and forecast, by product
8.3.2.2. France market size and forecast, by indication
8.3.2.3. France market size and forecast, by category
8.3.2.4. France market size and forecast, by end user
8.3.2.5. Germany market size and forecast, by product
8.3.2.6. Germany market size and forecast, by indication
8.3.2.7. Germany market size and forecast, by category
8.3.2.8. Germany market size and forecast, by end user
8.3.2.9. UK market size and forecast, by product
8.3.2.10. UK market size and forecast, by indication
8.3.2.11. UK market size and forecast, by category
8.3.2.12. UK market size and forecast, by end user
8.3.2.13. Rest of Europe market size and forecast, by product
8.3.2.14. Rest of Europe market size and forecast, by indication
8.3.2.15. Rest of Europe market size and forecast, by category
8.3.2.16. Rest of Europe market size and forecast, by end user
8.3.3. Europe market size and forecast, by product
8.3.4. Europe market size and forecast, by indication
8.3.5. Europe market size and forecast, by category
8.3.6. Europe market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key trends and opportunities
8.4.2. Asia-Pacific market size and forecast, by country
8.4.2.1. India market size and forecast, by product
8.4.2.2. India market size and forecast, by indication
8.4.2.3. India market size and forecast, by category
8.4.2.4. India market size and forecast, by end user
8.4.2.5. China market size and forecast, by product
8.4.2.6. China market size and forecast, by indication
8.4.2.7. China market size and forecast, by category
8.4.2.8. China market size and forecast, by end user
8.4.2.9. Japan market size and forecast, by product
8.4.2.10. Japan market size and forecast, by indication
8.4.2.11. Japan market size and forecast, by category
8.4.2.12. Japan market size and forecast, by end user
8.4.2.13. Australia market size and forecast, by product
8.4.2.14. Australia market size and forecast, by indication
8.4.2.15. Australia market size and forecast, by category
8.4.2.16. Australia market size and forecast, by end user
8.4.2.17. Rest of Asia-Pacific market size and forecast, by product
8.4.2.18. Rest of Asia-Pacific market size and forecast, by indication
8.4.2.19. Rest of Asia-Pacific market size and forecast, by category
8.4.2.20. Rest of Asia-Pacific market size and forecast, by end user
8.4.3. Asia-Pacific market size and forecast, by product
8.4.4. Asia-Pacific market size and forecast, by indication
8.4.5. Asia-Pacific market size and forecast, by category
8.4.6. Asia-Pacific market size and forecast, by end user
8.5. LAMEA
8.5.1. Key trends and opportunities
8.5.2. LAMEA market size and forecast, by country
8.5.2.1. Brazil market size and forecast, by product
8.5.2.2. Brazil market size and forecast, by indication
8.5.2.3. Brazil market size and forecast, by category
8.5.2.4. Brazil market size and forecast, by end user
8.5.2.5. Turkey market size and forecast, by product
8.5.2.6. Turkey market size and forecast, by indication
8.5.2.7. Turkey market size and forecast, by category
8.5.2.8. Turkey market size and forecast, by end user
8.5.2.9. South Africa market size and forecast, by product
8.5.2.10. South Africa market size and forecast, by indication
8.5.2.11. South Africa market size and forecast, by category
8.5.2.12. South Africa market size and forecast, by end user
8.5.2.13. Saudi Arabia market size and forecast, by product
8.5.2.14. Saudi Arabia market size and forecast, by indication
8.5.2.15. Saudi Arabia market size and forecast, by category
8.5.2.16. Saudi Arabia market size and forecast, by end user
8.5.2.17. Rest of LAMEA market size and forecast, by product
8.5.2.18. Rest of LAMEA market size and forecast, by indication
8.5.2.19. Rest of LAMEA market size and forecast, by category
8.5.2.20. Rest of LAMEA market size and forecast, by end user
8.5.3. LAMEA market size and forecast, by product
8.5.4. LAMEA market size and forecast, by indication
8.5.5. LAMEA market size and forecast, by category
8.5.6. LAMEA market size and forecast, by end user

CHAPTER 9: COMPANY PROFILES
9.1. Adapta Medical, Inc.
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Product portfolio
9.2. B. Braun Melsungen AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. Becton Dickinson And Company
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.4. Coloplast A/S
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. ConvaTec Healthcare B S..r.l.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. Cure Medical
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Product portfolio
9.6.4. Key strategic moves and developments
9.7. Hollister Inc.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.9. Medical Technologies of Georgia Inc.
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.10. Pennine Healthcare
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.11. Teleflex Incorporated
9.11.1. Company overview
9.11.2. Company snapshot
9.11.3. Operating business segments
9.11.4. Product portfolio
9.11.5. Business performance
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
According to a new report titled, Intermittent Catheters Market by Product, Indication, Category and End User: Global Opportunity Analysis and Industry Forecast, 2017-2023" the global intermittent catheters market was valued at $1,655.5 million in 2016, and is projected to reach $2,950.7 million by 2023, growing at a CAGR of 8.7% from 2017 to 2023. The female length catheters segment accounted for about half share of the global market in 2016.

Intermittent catheters are medical devices, which help to drain the urinary bladder in patients who lose control over their bladder. These catheters are inserted into the urethra and are guided to the bladder, which causes the urine to flow though the catheter tube and drain into the collection bag. Moreover, self-catheterization is possible using these catheters. Children aging seven or eight years can be trained to handle catheterization.

The major driving factors of intermittent catheters market include increase in geriatric population and rise in urinary incontinence. Furthermore, the introduction of favorable reimbursement policies for catheters is expected to supplement the market growth. However, the availability of alternatives to intermittent catheters and price competition at domestic level hamper the market growth. Conversely, the emerging economies are anticipated to offer lucrative opportunities, owing to rise is disposable income and increase in awareness towards intermittent catheters.

Among the product segment, uncoated intermittent catheters accounted for the maximum share in the global market, due to wide usage of uncoated catheters, owing to new materials used in the production of uncoated intermittent catheters to minimize allergies associated to latex material.

Among the indication segment, the urinary incontinence segment accounted for the maximum share, owing to increase in prevalence of urinary continence in both male and female population globally. For instance, urinary incontinence affects about 4-8% or 400 million individuals globally.

Key findings of the Intermittent Catheters Market:

The male length catheters segment accounted for about three-eighth share of the total market in 2016, and is expected to register a high CAGR of 8.4% from 2017 to 2023.
The hospitals segment accounted for three-seventh share of the total market and is expected to grow at a CAGR of 8.6% during the forecast period.
U.S. dominated the North American intermittent catheters market and is projected to grow at a CAGR of 7.0%.
Australia is the fastest growing country in the Asia-Pacific intermittent catheters market during the forecast period, registering a CAGR of 11.0%.
Ambulatory surgery centers accounted for one-third market share in 2016, and are expected to grow at a high CAGR of 8.9%.

In 2016, North America was the dominant revenue contributor, owing to high prevalence rate of urinary incontinence and surge in number of minimally invasive surgeries in the region. However, Asia-Pacific is expected to witness the highest CAGR during the forecast period, owing to the presence of high populace countries such as India and China, increase in awareness regarding intermittent catheters & urinary incontinence, and rise in disposable income.

The key players operating in the global intermittent catheters market are Adapta Medical, B. Braun Melsungen AG, Becton Dickinson Company, Coloplast A/S, ConvaTec Healthcare B S..r.l, Cure Medical, Hollister Inc., Medical Technologies of Georgia Inc., Pennine Healthcare and Teleflex Incorporated. Other players operating in the value chain are Hunter Urology, ASID BONZ, At Home Medical Products, Medical Technologies of Georgia and Hope Medical Supply Inc.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll